Drug Safety and Pharmacovigilance for Drugs, Biologics, and Devices

Describes the role of drug safety and pharmacovigilance in the development of new drugs, biologics, and devices.

Questions? Contact Us
Scroll Down Arrow


About this Webinar

Drug safety and pharmacovigilance are key in developing drugs, biologics, and medical devices. This webinar defines drug safety concepts and terms while detailing the types and sources of safety information. It describes the life cycle of handling individual case safety reports (ICSRs) and explores the interactions of drug safety and pharmacovigilance with other functional areas of biomedical product research.

Release Date: February 26, 2025

Language Availability: English

Suggested Audiences: Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), Contract Research Organizations (CROs), Faculty, Investigators, Research Administrators, Sponsors, Students

Organizational Subscription Price: Included as part of an annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person


Webinar Content

Drug Safety and Pharmacovigilance in Drugs, Biologics, and Devices

Maureen Quirk, MS, NRP

Learning Objectives:

  • Describe drug safety / pharmacovigilance.
  • Define safety vocabulary.
  • Detail the types and sources of safety information.
  • Explain the handling of safety information.
  • Describe the interaction of drug safety / pharmacovigilance with other functional areas.

Recommended Use: Required
ID (Language): 21335 (English)


Learn More

Your Name(Required)
I'd Like To Receive Emails From CITI Program
This field is for validation purposes and should be left unchanged.